Latest Eribulin Stories
Eisai Demonstrates Commitment to Patients with Rare Cancers WOODCLIFF LAKE, N.J., Feb. 25, 2015 /PRNewswire/ -- Eisai Inc.
FOR U.S. MEDIA ONLY WOODCLIFF LAKE, N.J., Dec.
The cancer drug eribulin, originally developed from sea sponges, could give women with advanced triple negative breast cancer an average of five extra months of life
Tokyo, Sept 17, 2014 - (JCN Newswire) - Eisai Co., Ltd.
Tokyo, July 3, 2014 - (JCN Newswire) - Eisai Co., Ltd.
Indication of Anticancer Agent Halaven for Use in Earlier-Line Treatment of Advanced Breast Cancer Tokyo, May 27, 2014 - (JCN Newswire)
Data underscore breadth of oncology portfolio WOODCLIFF LAKE, N.J., May 14, 2014 /PRNewswire/ -- Eisai Inc.
Patient Recruitment Now Underway at Treatment Centers Across the United States WOODCLIFF LAKE, N.J., Feb. 27, 2014 /PRNewswire/ -- Eisai Inc.
- In medieval musical notation, a sign or neume denoting a shake or trill.